23 May 2013
Keywords: Biosimilars, USA, Europe, Clinical data, Decision Resources
Article | 30 August 2011
The majority of US and European physicians are wary of using a biosimilar for an indication for which supporting clinical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 August 2011
22 May 2013
© 2013 thepharmaletter.com